NCT01731795View on ClinicalTrials.gov

Efficacy Study of Dexamethasone to Treat the Acute Respiratory Distress Syndrome

PHASE4CompletedINTERVENTIONAL
Enrollment

277

Participants

Timeline

Start Date

March 28, 2013

Primary Completion Date

February 12, 2019

Study Completion Date

February 12, 2019

Conditions
Acute Respiratory Distress Syndrome
Interventions
DRUG

Dexamethasone

Dexamethasone (20 mg/iv/daily/from Day 1 of randomization during 5 days, followed by 10 mg/iv/daily/ from Day 6 to 10 of randomization)

Trial Locations (2)

35010

Hospital Universitario Dr. Negrin, Las Palmas de Gran Canaria

Unknown

Hospital Clinico de Valencia, Valencia

All Listed Sponsors
collaborator

Fundación Mutua Madrileña

OTHER

collaborator

Asociación Científica Pulmón y Ventilación Mecánica

OTHER

lead

Dr. Negrin University Hospital

OTHER

NCT01731795 - Efficacy Study of Dexamethasone to Treat the Acute Respiratory Distress Syndrome | Biotech Hunter | Biotech Hunter